Book Value per Share: NAYA Biosciences (NAYA)

Public company logo of NAYA Biosciences Inc (NAYA)

Patents for antibodies targeting autoimmune diseases and breast cancer help NAYA Biosciences (NAYA) attract venture capital investments despite R&D expenditures. The book value per share confirms this resilience, with the current value of the metric standing at -19.09. NAYA Biosciences (NAYA) is scaling the expansion of its NY-303 drug for liver cancer therapy by implementing the Flex-NK platform to activate NK cells in tumor treatment.

NAYA Biosciences Inc (NAYA) - Accounting Value per Share from 07/04/2022 to 04/28/2025

Summary analytical data breakdowns for nayabiosciences.com (NAYA)

- price and consensus price forecast:
Stock Quotes NAYA Bio|NAYA - Average Forecast Price
- market capitalization data:
Market Capitalization NAYA Biosciences Inc.|NAYA - Enterprise Value
- book capitalization data:
Book Value per Share NAYA Biosciences|NAYA - Company Net Assets|Market Capitalization to Book Value Ratio nayabiosciences.com|NAYA - Company Total Assets
- debt and liquidity data:
Debt to Equity NAYA Biosciences|NAYA - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital NAYA Biosciences Inc.|NAYA - Company Total Debt|Debts to Book Capitalization NAYA Biosciences Inc.
Analysis of all company metrics:NAYA Bio, NAYA
Manufactured product of nayabiosciences.com

Book value per share is defined as the difference between a company's total assets and liabilities, divided by the total number of outstanding securities. This indicator reflects the actual value of net assets, which is critical for NAYA Biosciences (NAYA) as it scales the Flex-NK platform in oncology and reproduction, while the current book value per share illustrates the efficiency of capital management.

Competitor analysis for NAYA Biosciences

ONC (BeiGene Corp) - Accounting Value per Share|HALO - Net Asset Value per Share|RVMD: Book Value per Share|ascentage.com (AAPG) - Book Value per Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|FATE - Accounting Value per Share|Aadi Bio - Accounting Value per Share|TCRX: Book Value per Share|Net Assets per Single Share championsoncology.com CSBR|XBiotech (XBIT) - Accounting Value of a Share|Book Value per Share CVM (CEL-SCI Corp.)|Net Asset Value per Share OSTX|Net Assets per Single Share Radiopharm Theranostics Limited RADX|Equity per Share artivabio.com (ARTV)|Book Value per Share ANL (Adlai Nortye)|VERU - Book Value per Share|TPST (Tempest Tx) - Accounting Value per Share|XLO - Net Asset Value per Share|RENB: Book Value per Share|Book Value per Share Mural Oncology|KAPA - Accounting Value per Share|Accounting Value of a Share OnKure|Book Value per Share CytoMed Therapeutics (GDTC)|Net Assets per Single Share curis.com (CRIS)|Book Value per Share APLM|tharimmune.com - Net Assets per Share|ADVB (Advanced Biomed Corp) - Net Assets per Single Share|GNPX: Net Asset Value per Share|calidibio.com - Net Assets per Single Share|Sunshine Biopharma Inc. (SBFM) - Net Assets per Share|Book Value per Share XBIO|Accounting Value per Share salariuspharma.com|PPBT (Purple Biotech Ltd.) - Book Value per Share|Net Assets per Share aoncology.com (AONC)|BGNE: Book Value per Share|Checkpoint Therapeutics Inc - Net Asset Value per Share|Elevation Oncology, Inc. (ELEV) - Net Assets per Single Share|ICAD - Equity per Share|IKNA (ikenaoncology.com) - Book Value per Share|Notable Labs Ltd (NTBL) - Accounting Value per Share|Book Value per Share VIRX (Viracta Therapeutics Inc.)|Net Asset Value per Share MOR|AAPGV (Ascentage Pharma Group) - Net Assets per Single Share